🇺🇸 FDA
Patent

US 7842729

Anti tubercular drug: compositions and methods

granted A61KA61K31/132A61K31/133

Quick answer

US patent 7842729 (Anti tubercular drug: compositions and methods) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Nov 30 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/132, A61K31/133, A61K31/137, A61K31/40